Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 30 for “"Drug Synergy"”.
-
DRUG SYNERGY, TARGETING EVOLUTIONARY CONSERVED LONGEVITY AND AGING NETWORKS TO EXTEND HEALTHY LIFESPAN
… in adults and, ideally, repurpose existing drugs. I show that dramatic lifespan extension can be achieved by targeting multiple, evolutionarily conserved aging pathways and mechanisms using drug combinations. Using this approach in C. elegans, I was able to slow aging and significantly …
-
End-to-end trainable deep tensor completion algorithms with multimodal data fusion for anticancer drug synergy prediction
Computational algorithms for anticancer drug synergy prediction (ACDSP) have the potential to discover novel anticancer drug combinations. Most of the algorithms are based on deep learning (DL) and use chemical features of anticancer drugs and multiomic features of cancer cell lines. Deep tensor …
-
Localization of the Human Malaria Parasite's Dihydrofolate Reductase-Thymidylate Synthase and Examining Its Role in Proguanil and Atovaquone Drug Synergy
… rapid ability of the parasite to acquire drug resistance emphasizes the need to find new drugs to treat individuals and prevent infection. In the race to develop new drugs, elucidation of the exact mechanisms of older drugs and their targets is sometimes left unresolved. Dihydrofolate …
-
Deep Learning Applications for Predictive Modeling in Cancer Therapy and Enzyme Encoding
… with capturing the complex interactions between drugs and biological networks, as well as representing hierarchical relationships within enzyme classifications. This dissertation addresses these limitations by developing advanced deep learning models tailored to enhance predictive performance in …
-
EFFECT OF ENVIRONMENTAL IRON ON GROWTH PATTERNS, BIOFILM FORMATION, AND ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA GLABRATA
… to modulate C. albicans pathogenesis and affect drug-susceptibility. Here, we assess the effect of iron on the growth, antifungal-susceptibility, biofilms, and cell wall of C. glabrata.Methods: Growth, minimal inhibitory concentration (MIC), and biofilm experiments were conducted using 96-well …
-
Design and Evaluation of Network Algorithms and Deep Learning Models in Systems Biology and Biomedicine
… systematically evaluate deep learning models for drug synergy prediction, an important challenge in combination therapy design. Using the SynVerse framework, we assess 16 models across diverse feature types and deep learning based architectures and demonstrate that models often exploit …
-
Machine Learning Approaches for Drug Combination Discovery
Drugs used in combination therapy has superior treatment efficacy. Preclinical experimental screenings have fueled this progress by identifying and prioritizing new candidate combinations, but they lack predictive power over the transcriptomic data of individualized cancer samples in which …
-
COMBINATION THERAPY THROUGH PLATINUM (IV) PRODRUG COMPLEXES INCORPORATING SELF-IMMOLATING LINKERS
… initiated research into the field of metallodrugs. However, the efficacy of cisplatin is hampered by low selectivity and severe side effects. In combination chemotherapy, drugs with different physical properties may also not be delivered synchronously. We investigated the conjugation of …
-
Discovery and Development Strategies of Combination Nanomedicines for Childhood Blood Cancers
… to maximize the therapeutic potential of novel drug combinations: (i) use tyrosine kinase inhibition to exploit ectopic molecular vulnerabilities; (ii) identify synergistic drug ratios that amplify tumor cell killing; and (iii) formulate therapeutic combinations in liposomal nanocarriers for …
-
Informing Precision Medicine Through Data-driven Modeling of Patient-specific Therapeutic Responses in Microfluidic-based Assays
… time, and reliant on reported mechanisms of drug action and patient response. Microfluidic devices provide a way to directly and efficiently test small quantities of patient samples and screen for functional outcomes; these devices can incorporate features such as the cellular environment to …
-
Rationalising Multi-Agent Chemotherapy through Systems Analysis of Drug-Induced Apoptosis for High-Risk Neuroblastoma
… to identify and define the emergence of synergy between relevant chemotherapy drug combinations. Firstly, a functional genomics screen was performed on a high content cellomics platform with a siRNA library of 200 apoptotic genes with current standard-of-care chemotherapy and preclinical …
-
Off-Target Based Drug Repurposing Using Systems Pharmacology
The goal of this study was to identify novel drug repurposing opportunities in cancer by utilizing the off-target profiles of clinically relevant kinase inhibitors. This was based on the observation that the global target profiles of compounds are largely ignored and that many compounds have …
-
Functional Genomics identify Novel Therapeutic Vulnerabilities in Retinoblastoma
… topotecan (TPT), standard-of-care chemotherapy. Synergy operated via increased DNA damage, activation of CHK kinases, and engagement of the p53-BAX pro-apoptotic pathway. We also identified a tumor insensitive to B02+TPT, paradoxically exhibiting elevated DNA damage. In this case, a subset of …
-
LOOKING TO THE FUTURE OF STROKE TREATMENT: COMBINING RECANALIZATION AND NEUROPROTECTION IN ACUTE ISCHEMIC STROKE
… in the clinical setting. Also, current routes of drug administration, intraperitoneal and intravenous, do not mimic the clinical route of intra-arterial drug administration. To bridge this divide, we have retro-engineered a mouse model of stroke from the current standard of care for emergent large …
-
Tackling Triple-Negative Breast Cancer with a Novel Glucose Transporter Inhibitor and an Antidiabetic Biguanide
… screen with rapaglutin A and the Johns Hopkins Drug Library in MDA-MB-231 cells revealed that phenformin and rapaglutin A synergistically inhibit the proliferation of MDA-MB-231 cells. Ensuing mechanistic studies suggested that low glucose levels improve phenformin’s synthetic lethality in the …
-
EXTENDING HEALTHY LIFESPAN BY SYSTEMATICALLY TARGETING AGEING PATHWAYS SYNERGIES
… diseases in aging populations. Work on drugs and genes that affect lifespan in model organisms shows that the most significant lifespan effects result from pathway synergy and drug-drug interactions. Currently, it is unclear how common such synergistic interactions are or how best to …
-
Siramesine and lapatinib induce synergic cell death via a ferroptotic mechanism in lung adenocarcinoma and glioblastoma cells
… inhibited, contributing to the development of drug resistance. Identifying and exploiting alternative cell death pathways are essential to overcoming or bypassing drug resistance. Ferroptosis, a newly described, morphologically and biochemically distinct, cell death mechanism is characterized …
-
Actinomycin D and Telmisartan Combination Therapy Targets Lung Cancer Stem Cells
… has been attributed partly to the development of drug resistance, however the underlying cellular and molecular mechanisms are poorly understood. It has been suggested that a very small group of specific cells within the heterogeneous tumors, cancer initiating stem cells (CSC), develop resistance …
-
Development of RNA Aptamers and Antidotes as Antithrombotic Therapeutics
… two anticoagulant aptamers to assess potential drug synergy. Several combinations of two anticoagulant aptamers were synergistic and severely impaired blood clot formation. One specific pair of aptamers that targeted factor X (FX) and prothrombin in combination was extremely potent and could …
-
Metformin as a potential therapy for malignant astrocytoma
… Metformin is from the biguanide family of drugs and is the most common medication used in the treatment of type 2 diabetes. Clinical studies have reported that, in type 2 diabetic patients, metformin might reduce cancer incidence and severity. Currently, metformin is being assessed in …
Page 1 of 2